Yıl: 2019 Cilt: 26 Sayı: 9 Sayfa Aralığı: 1997 - 2001 Metin Dili: İngilizce DOI: 10.5455/annalsmedres.2019.04.218 İndeks Tarihi: 16-01-2020

How should we approach thyroidal incidentalomas detected on FDG-PET/ CT imaging?

Öz:
Aim: Thyroidal incidentalomas (Tis) detected by F-18 fluorodeoxyglucose positron emission tomography/computed tomography(F-18FDG PET/CT) may be associated with three different causes that include metastasis of another malignancy, primary thyroidgland malignancies and lastly benign thyroidal nodules, all require different clinical approaches. For appropriate treatment, quickcharacterization of the Ti is important, preferably with a lesser invasive method. Our aim was to determine whether the characterizationof TIs can be performed with FDG-PET/CT, due to contribute faster diagnosis, and initiation of the therapy.Material and Methods: Forty-four patients with detected TIs in FDG-PET/CT were included in the study. The relationship betweenmetabolically/morphological parameters and pathology results were evaluated statistically. If two subsequent cytology werenegative, nodule accepted as benign. If cytology result was suspected or malignant, histopathological confirmation was made. Forthese patients, histopathological results were accepted as definite diagnosis.Results: Malignant thyroidal pathologies were detected in 29.5% of patients. We could not find any significant relationship betweenage, nodule size and SUVmax value and pathology results. According to ROC analysis, there were not any cut-off value for nodulesize and SUVmax. Similar results were also obtained for papillary carcinoma as a special subgroup.Conclusion: Characterisation of TIs could not be performed by using age, nodule size and SUVmax. Therefore, TIs which detected byFDG-PET/CT should be examined pathologically due to high risk of malignancy.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Reum CA, Min JH, Ho LS, et al. Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography endocrinol metab 2015;30:71-7.
  • 2. Tan GH, Gharib H. Thyroid incidentalomas: management approaches to nonpalpable nodules discovered incidentally on thyroid imaging. Ann Intern Med 1997;126:226–31
  • 3. Mortensen JD, Woolner LB, Bennett WA. Gross and microscopic findings in clinically normal thyroid glands. J Clin Endocrinol Metab 1955;15:1270–80.
  • 4. Iyer NG, Shaha AR. Management of Thyroid Nodules and Surgery for Differentiated Thyroid Cancer. Clin Oncol 2010;22:405-12.
  • 5. Lawal IO, Nyakale NE, Harry LM et al. Higher preablative serum thyroid stimulating hormone level predicts radioiodine ablation effectiveness in patients with differentiated thyroid carcinoma. Nucl Med Commun 2017;38:222-7.3.
  • 6. Dean DS, Gharib H. Epidemiology of Thyroid Nodules. Best Prac Res Clin Endocrin Metab 2008;22:901-11.
  • 7. Lonsdale MN, Beyer T. Dual-modality PET/CT instrumentation: today and tomorrow. Eur J Radiol 2010;73:452–60.
  • 8. Kresnik E, Gallowitsch HJ, Mikosch P, et al. Fluorine-18- fluorodeoxyglucose positron emission tomography in the preoperative assessment of thyroid nodules in an endemic goiter area. Surgery 2003;133:29.
  • 9. Chen YK, Ding HJ, Chen KT, et al. Prevalence and risk of cancer of focal thyroid incidentaloma identified by f-fluorodeoxyglucose positron emission tomography for cancer screening in healthy subjects antıcancer research 2005;25:1421-6.
  • 10. Bertagna F, Treglia G, Piccardo A, et al. Diagnostic and clinical significance of F-18-FDG-PET/CT thyroid incidentalomas. J Clin Endocrinol Metab 2012;97:3866-7.
  • 11. Nam SY, Roh JL, Kim JS, et al. Focal uptake of 18F fluorodeoxyglucose by thyroid in patients with nonthyroidal head and neck cancers. Clin Endocrinol 2007;67:135–9.
  • 12. Lee WM, BJ Kim, Kim MH, et al. Characteristics of thyroid incidentalomas detected by pre-treatment [18F]FDG PET or PET/CT in patients with cervical cancer J Gynecol Oncol 2012;23:43-7.
  • 13. Albes JM, Dohmen BM, Schott U, et al. Value of positron emission tomography for lung cancer staging. Eur J Surg Oncol 2002;28:55–62.
  • 14. Hegedus L. Clinical practice: the thyroid nodule. N Engl J Med 2004;351:1764-71.
  • 15. Yaylali O, Kirac FS, Yuksel D, et al. Evaluation of focal thyroid lesions incidentally detected in fluorine-18- fluorodeoxyglucose positron emission tomography/ computed tomography images. Indian J Cancer 2014;51:236-40.
  • 16. Kim TY, Kim WB, Ryu JS, et al. 18Ffluorodeoxyglucose uptake in thyroid from positron emission tomography (PET) for evaluation in cancer patients: high prevalence of malignancy in thyroid PET incidentaloma. Laryngoscope 2005;115:1074–8.
  • 17. Sinae L, Taegyu P, Soyeon P, et al. The Clinical Role of Dual- Time-Point 18F-FDG PET/CT in Differential Diagnosis of theThyroid Incidentaloma Nucl Med Mol Imaging 2014;48:121–9.
  • 18. Jamsek J, Zagar I, Gaberscek S, et al. Thyroid lesions incidentally detected by 18F-FDG PET-CT ― a two centre retrospective study Radiol Oncol 2015;49:121.
  • 19. Kim BH, Kim SJ, Kim H, et al. Diagnostic value of metabolic tumor volume assessed by 18F-FDG PET/CT added to SUVmax for characterization of thyroid 18F-FDG incidentaloma Nuclear Medicine Communications 2013;34;868–76.
  • 20. Soelberg KK, Bonnema SJ, Brix TH, et al. Risk of malignancy in thyroid incidentalomas detected by 18F-fluorodeoxyglucose positron emission tomography: a systematic review. Thyroid 2012; 22:918–25.
  • 21. Kim BH, Na MA, Kim IJ, et al. Risk stratification and prediction of cancer of focal thyroid fluorodeoxyglucose uptake during cancer evaluation Ann Nucl Med 2010;24:721–8.
  • 22. Kim H, Seong-Jang K, Kim IJ, et al. Thyroid Incidentalomas on FDG PET/CT in Patients with Non-Thyroid Cancer a Large Retrospective Monocentric Study Onkologie 2013;36:260– 4.
  • 23. Adas M, Adas G, Koc B, et al . Incidental thyroid lesions. on FDG-PET/CT: a prevalence study and proposition of management Minerva Endocrinologica 2015;40:169-75.
  • 24. Pagano L, Sama MT, Morani F, et al. Thyroid incidentaloma identified by 18F fluorodeoxyglucose positron emission tomography with CT (FDG-PET/CT): clinical and pathological relevance Clinical Endocrinology 2011;75,528-34.
  • 25. Shie P, Cardarelli R, Sprawls K, et al. Systematic review: prevalence of malignant incidental thyroid nodules identified on fluorine-18 fluorodeoxyglucose positron emission tomography. Nucl Med Comm 2009;30:742-748.
  • 26. Kang KW, Kim SK, Kang HS, et al. Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for metastasis evaluation and cancer screening in healthy subjects. J Clin Endocrinol Metab 2003;88:4100-4.
  • 27. Choi JW, Yoon YH, Yoon YH,et al. Characteristics of primary papillary thyroid carcinoma with false-negative findings on initial (18)F-FDG PET/CT. Ann Surg Oncol 2011;18:1306-11.
  • 28. Di Pasquale M, Rothstein JL, Palazzo JP. Pathologic features of Hashimoto’s associated papillary thyroid carcinoma. Human Pathology 2001;32,24-30.
  • 29. Ohba K, Nishizawa S, Matsushita A, et al. High incidence of thyroid cancer in focal thyroid incidentaloma detected by 18F-fluorodexyglucose positron emission tomography in relatively young healthy subjects: results of 3-year followup Endocrine Journal 2010,57, 395-401.
  • 30. Kim MJ, Kim EK, Park SI, et al. US-guided fine-needle aspiration of thyroid nodules: indications, techniques, results. Radiographics 2008; 28:1869-86.
APA Şimşek F, KUŞLU D, BALCI T, UĞUR K, Koç Z, ARTAŞ H, Ozercan I, NARİN Y (2019). How should we approach thyroidal incidentalomas detected on FDG-PET/ CT imaging?. , 1997 - 2001. 10.5455/annalsmedres.2019.04.218
Chicago Şimşek Fikri Selçuk,KUŞLU Duygu,BALCI Tansel Ansal,UĞUR Kader,Koç Zehra Pınar,ARTAŞ Hakan,Ozercan Ibrahim Hanifi,NARİN Yavuz How should we approach thyroidal incidentalomas detected on FDG-PET/ CT imaging?. (2019): 1997 - 2001. 10.5455/annalsmedres.2019.04.218
MLA Şimşek Fikri Selçuk,KUŞLU Duygu,BALCI Tansel Ansal,UĞUR Kader,Koç Zehra Pınar,ARTAŞ Hakan,Ozercan Ibrahim Hanifi,NARİN Yavuz How should we approach thyroidal incidentalomas detected on FDG-PET/ CT imaging?. , 2019, ss.1997 - 2001. 10.5455/annalsmedres.2019.04.218
AMA Şimşek F,KUŞLU D,BALCI T,UĞUR K,Koç Z,ARTAŞ H,Ozercan I,NARİN Y How should we approach thyroidal incidentalomas detected on FDG-PET/ CT imaging?. . 2019; 1997 - 2001. 10.5455/annalsmedres.2019.04.218
Vancouver Şimşek F,KUŞLU D,BALCI T,UĞUR K,Koç Z,ARTAŞ H,Ozercan I,NARİN Y How should we approach thyroidal incidentalomas detected on FDG-PET/ CT imaging?. . 2019; 1997 - 2001. 10.5455/annalsmedres.2019.04.218
IEEE Şimşek F,KUŞLU D,BALCI T,UĞUR K,Koç Z,ARTAŞ H,Ozercan I,NARİN Y "How should we approach thyroidal incidentalomas detected on FDG-PET/ CT imaging?." , ss.1997 - 2001, 2019. 10.5455/annalsmedres.2019.04.218
ISNAD Şimşek, Fikri Selçuk vd. "How should we approach thyroidal incidentalomas detected on FDG-PET/ CT imaging?". (2019), 1997-2001. https://doi.org/10.5455/annalsmedres.2019.04.218
APA Şimşek F, KUŞLU D, BALCI T, UĞUR K, Koç Z, ARTAŞ H, Ozercan I, NARİN Y (2019). How should we approach thyroidal incidentalomas detected on FDG-PET/ CT imaging?. Annals of Medical Research, 26(9), 1997 - 2001. 10.5455/annalsmedres.2019.04.218
Chicago Şimşek Fikri Selçuk,KUŞLU Duygu,BALCI Tansel Ansal,UĞUR Kader,Koç Zehra Pınar,ARTAŞ Hakan,Ozercan Ibrahim Hanifi,NARİN Yavuz How should we approach thyroidal incidentalomas detected on FDG-PET/ CT imaging?. Annals of Medical Research 26, no.9 (2019): 1997 - 2001. 10.5455/annalsmedres.2019.04.218
MLA Şimşek Fikri Selçuk,KUŞLU Duygu,BALCI Tansel Ansal,UĞUR Kader,Koç Zehra Pınar,ARTAŞ Hakan,Ozercan Ibrahim Hanifi,NARİN Yavuz How should we approach thyroidal incidentalomas detected on FDG-PET/ CT imaging?. Annals of Medical Research, vol.26, no.9, 2019, ss.1997 - 2001. 10.5455/annalsmedres.2019.04.218
AMA Şimşek F,KUŞLU D,BALCI T,UĞUR K,Koç Z,ARTAŞ H,Ozercan I,NARİN Y How should we approach thyroidal incidentalomas detected on FDG-PET/ CT imaging?. Annals of Medical Research. 2019; 26(9): 1997 - 2001. 10.5455/annalsmedres.2019.04.218
Vancouver Şimşek F,KUŞLU D,BALCI T,UĞUR K,Koç Z,ARTAŞ H,Ozercan I,NARİN Y How should we approach thyroidal incidentalomas detected on FDG-PET/ CT imaging?. Annals of Medical Research. 2019; 26(9): 1997 - 2001. 10.5455/annalsmedres.2019.04.218
IEEE Şimşek F,KUŞLU D,BALCI T,UĞUR K,Koç Z,ARTAŞ H,Ozercan I,NARİN Y "How should we approach thyroidal incidentalomas detected on FDG-PET/ CT imaging?." Annals of Medical Research, 26, ss.1997 - 2001, 2019. 10.5455/annalsmedres.2019.04.218
ISNAD Şimşek, Fikri Selçuk vd. "How should we approach thyroidal incidentalomas detected on FDG-PET/ CT imaging?". Annals of Medical Research 26/9 (2019), 1997-2001. https://doi.org/10.5455/annalsmedres.2019.04.218